Advik Laboratories Board Meeting on Aug 13 to Approve Q1 FY27 Results

Advik Laboratories Ltd has announced that its Board of Directors will convene on August 13, 2026, at 12:00 PM at its corporate office in New Delhi. The primary agenda is to consider and approve the Un-Audited Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. Additionally, the board may discuss other business matters. In line with SEBI regulations and the company's insider trading code, the trading window for designated employees and their relatives remains closed until August 15, 2026, to prevent any potential misuse of information related to the financial results.